🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is aimed at the evaluation of the safety and clinical a...
Status
Terminated
Location
UPMC Hillman Cancer Center
Start Date
2023-08-10
Trial ID
NCT05746481
Treatments Being Tested
This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2025-02-18
Trial ID
NCT06754930
Treatments Being Tested
To evaluate the efficacy and safety of P nab-paclitaxel combined with carbo...
Status
Withdrawn
Location
Fourth Hospital of Hebei Medical University
Start Date
2019-05-10
Trial ID
NCT04067102
Prevention of infectious diseases through immunization is one of the greate...
Status
Completed
Location
Radboud University Medical Center
Start Date
2019-04-08
Trial ID
NCT04212377
Treatments Being Tested
The purpose of this study is to assess the anti-tumor activity and safety o...
Status
Recruiting
Location
University of California at San Diego
Start Date
2022-11-11
Trial ID
NCT05498428
This is a phase 1 clinical trial to evaluate the safety, feasibility and im...
Status
Not Yet Recruiting
Location
Washington University School of Medicine
Start Date
2026-08-01
Trial ID
NCT07300475
Studies on postoperative adjuvant albumin paclitaxel in domestic breast can...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-07-10
Trial ID
NCT05420467
Not randomized, multicentric, national phase II trial estimating the effica...
Status
Completed
Location
Centre Paul Papin
Start Date
2009-03-13
Trial ID
NCT00864318
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Veterans Affairs Medical Center - Phoenix (Hayden)
Start Date
2000-11
Trial ID
NCT00022217
Treatments Being Tested
This is a first-in-human, open-label, dose escalation study to evaluate the...
Status
Completed
Location
UCLA Medical Hematology & Oncology
Start Date
2013-11-15
Trial ID
NCT02009449